Use of non‐LDL‐C lipid‐lowering medications in patients with type 2 diabetes

BACKGROUND: A number of non‐low‐density lipoprotein cholesterol lipid abnormalities are associated with type 2 diabetes and insulin resistance, which may lead practitioners to use medications targeting these abnormal lipid fractions despite a lack of evidence or guideline recommendations. METHODS AN...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnold, Suzanne V., Gosch, Kensey, Wong, Nathan D., Hejjaji, Vittal, Goyal, Abhinav, Leiter, Lawrence A., Kosiborod, Mikhail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375067/
https://www.ncbi.nlm.nih.gov/pubmed/32704552
http://dx.doi.org/10.1002/edm2.126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375067/
https://www.ncbi.nlm.nih.gov/pubmed/32704552
http://dx.doi.org/10.1002/edm2.126

Ejemplares similares